FDA Watching India Pharmaceuticals With a Closer Eye

Pharmaceutical companies in India have been subject to more scrutiny and oversight by the U.S. Food and Drug Administration due to recent events of bad practice at a handful of facilities, according to a report by The New York Times.

Read the full story on Becker's Hospital Review.

More Articles on Pharmaceuticals:

Salix Pharmaceuticals Acquires Santarus
Abrams Royal Pharmacy Issues Voluntary Recall on All Unexpired Sterile Products
Valeant Pharmaceuticals International to Acquire Solta Medical for $250M